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The disproportion between the num-
ber of recipients and donors of organs 
for transplantation is one of the most 
important challenges of contempora-
ry transplantation medicine. The pool 
of organs for transplantation may be 
increased through an increase in the 
procedures of their harvesting from 
living donors.
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Kidney transplantation from a living donor is a method of choice in the treatment of end-stage renal disease. 
The programme of care for a living kidney donor should cover the assessment of health status and quality of 
life and an analysis of the data collected on the basis of the same criteria. The conclusions drawn should be 
used in the assessment of the risk associated with the kidney harvesting procedure, assessment of the health 
status of the living donor and an improvement of the results of kidney transplantation from a living donor. 
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The disproportion between the number of reci-pients and donors of organs for transplantation is one of the most important challenges of 
contemporary transplantation medicine. The pool of 
organs for transplantation may be increased in the 
procedures of their harvesting from living donors. 
Kidney transplantation from a living donor is a method 
of choice in the treatment of end-stage renal disease. 
The best results of treatment of end-stage renal dise-
ase are obtained in the predialysis period. In Poland, 
only 5% of renal transplantations in the general pools 
are kidneys harvested from a living donor (in contrast 
to approximately 50% in Scandinavia). An essential 
issue is to develop a system which would ensure, 
through the process of screening tests and care for 
the living kidney donor, the safety of the conducted 
procedure and a long-term follow-up of donor’s he-
alth after the kidney removal surgery. 
Kidney transplantation from a living donor is an 
operation that brings benefits to the recipient. On the 
other hand, it is associated with the risk borne by the 
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donor. This risk is related both to the surgery itself as 
well as to the consequences of living with only one 
kidney. Harvesting the kidney for transplantation from 
a living donor is a complex surgical procedure which 
does not improve the donor’s health. The prospecti-
ve donor must meet strict health and psychological 
criteria to be found eligible for the surgery. In scien-
tific literature there are many examples proving that 
the procedure of kidney transplantation from a living 
donor is safe for the donor in the early and late pe-
riod after the donation. (1, 2) Along with the growing 
number of transplantations performed, loosening of 
medical (3, 4) (age, obesity, arterial hypertension well 
controlled by monotherapy) and psychosocial (5) (un-
related donors) criteria for donors is being observed, 
which is associated with an increase of prospective 
eligible donors for living kidney donation. Most of the 
observations concerning the health status of living 
kidney donors presented in the literature apply to pa-
tients originating from one transplant centre. In many 
cases, the data are incomplete, the studies are con-
ducted retrospectively, and the research methodolo-
gy varies. The system of providing medical care for 
the living kidney donor should also be rooted in the 
legislation in force in the territory of a given country. 
The most important piece of legislation regulating the 
transplantation issued in the territory of the European 
Union is the Directive of the European Parliament and 
of the Council 2010/53/EU of 7 July 2010. In Poland, 
the legal regulations related to transplantation are 
contained in the Transplantation Act of 1 July 2005, 
concerning the procurement, storage and transplan-
tation of cells, tissues and organs. The issues related 
to living donations are regulated by Chapter 3 of this 
Act, titled: “Procurement of cells, tissues or organs 
from living donors”. The principles of harvesting, sto-
ring and transplanting cells, tissues and organs are 
defined in that Chapter. The Act defines inter alia the 
legal framework of transplanting organs from a living 
donor. The health requirements that must be met by 
a donor of cells, tissues and organs are stated in the 
Regulation of the Minister of Health of 25 April 2006. 
(6) Moreover, it includes a list of diagnostic exami-
nations and tests and contraindications to donation. 
The Regulation also defines the type and scope of 
tests of living organ donors performed within the 
framework of their health monitoring. 
There are a number of contraindications to dona-
tions. Those listed in Table 1 were established at a 
conference on the procurement and transplantation 
of organs from living donors that was held in Amster-
dam in 2004. These contraindications are used  in 
Poland. In such countries as Canada or the United 
Kingdom, donor exclusion criteria developed by local 
institutions are used. (7, 8) Moreover, European and 
American organizations have developed the respecti-
ve guidelines. (9, 10) 
The basic screening tests are performed at the 
regular medical centre of the kidney recipient. The 
remaining diagnostic and laboratory tests and exa-
minations as well as the necessary consultations are 
performed at the transplant Centre. The required exa-
minations and tests are listed in Table 2. (11) 
If a disease is diagnosed in the prospective donor  
in the screening process, such a person is found 
temporarily or finally ineligible for surgery. The 
prospective donor is referred to further diagnostics 
and treatment. (13) It should be emphasized that the 
screening process and the medical examinations 
make it possible to detect and diagnose early the 
disorders of which the prospective donor is unaware, 
which increases the chance for curative treatment. It 
is the direct benefit that the prospective donor may 
obtain. Despite loosening of the criteria, less than 
a half of potential living donors meet the donation 
requirements. (9, 14) At the Centre employing the 
author, this percentage is similar, and the analysis 
of the screening process was conducted by  Dr 
Gozdowska et al. (13) The study applied to the 
screening process of 124 potential donors for 111 
kidney recipients in 2007 – 2011. As shown by the 
results, non-eligibility causes were: 
• medical reasons (39.7%), 
• cadaveric renal transplantation (25%), 
• immune factors (23.5%), 
• consent withdrawal by the donor (4.6%), 
• psychological and social factors (4.4%). 
Romagnolli et al. (15) described similar causes of 
non-eligibility. The main causes were medical factors 
increasing the cardiovascular risk. 
Harvesting a kidney from a living donor is possible 
only when the donor has been fully informed of the 
possible complications, the risk of surgery is small 
and the transplantation has a high chance for suc-
cess. The donor’s must be fully informed and con-
sent must be voluntary. (8) The donor may withdraw 
the consent until the surgery itself. 
The donor who donated regenerating cells and 
tissues more than once and the organ donor have the 
right to the title of the “Distinguished Graft Donor”. 
(16) This title is assigned at a request of the Polish 
Transplant Coordinating Centre Poltransplant and 
gives the right, for example, to jump the queue in 
pharmacies and health establishments. 
There are no clear global or European guidelines 
which would state precisely the scope of tests per-
formed in the course of the control and on the length 
of time for which the care for the donor is to be pro-
vided. Under the Transplantation Act (16), in Poland 
transplant centres are responsible for the care for the 
living kidney donor. The care must be provided for up 
to 10 years after transplantation. (16) The Regulation 
of the Minister of Health (14) includes the informa-
tion what examinations and tests are to be perfor-
med at the follow-up visit of a living kidneys donor 
at the transplant centre. In line with this Regulation, 
cerning the health status of donors, are to be entered 
into the Register of the Living Donor operating since 
1 January 2007. This register covers liver and kidney 
donors. Transplant centres are responsible for upda- 
ting the data in the register. The purpose of keeping 
the register is health monitoring and creating a safe 
system of care for donors. In 2013, the Register of 
Living Donors was supplemented by donors of earlier 
years, i.e. starting from 1967. The extent of upda-
ting the data in the Register of Living Donors is still 
unsatisfactory. Follow-up examination at 5 years after 
the operation are entered into the register on average 
only in 11%. In view of the small number of data, the 
register does not perform its function of a tool for 
the monitoring and assessment of health status of a 
living donor. (21) 
An important aspect of building a correctly opera-
ting healthcare system is the method of its finan-
cing.  This issue applies to numerous countries, 
including Poland, and the existing financing methods 
are based mainly on public sources or on private 
insurers. Professor Wojciech Rowiński considered 
the donated kidney to be an input made by living 
donors into the healthcare system in the area of 
transplantation. According to Prof. Rowiński, it is the 
State which is responsible for developing a healthca-
re system in the form of outpatient care as well as 
compensation for lost earnings. In many cases, in-
sufficient funds are the reason for the lack of medical 
care for the living kidney donor. Moreover, increasing 
migration of the society is important in the aspect of 
developing a system of care for the living donor. The 
aim should be to develop such mechanisms which 
will make it possible to provide care for a living donor 
not only at the centre where transplantation was 
performed but also at the nearest place of permanent 
residence of the donor. 
On the basis of surveys, Waterman et al. (17) spe-
cified the causes of improper operation of the 
long-term system of care for the living donor in the 
United States. The main factor of the inappropriately 
functioning programme of care for the living donor is 
the donors’ unwillingness to participate in the pro-
gramme. More than half of the respondents indicated 
financial reasons – the lack of possibility to finance 
the procedures performed within the framework of 
the care for the donor at transplant centres and the 
lack of compensation for the costs borne by the do-
nors related to examinations and tests and to getting 
to the follow-up visit. 
So far, more than 250 kidneys have been transplan-
ted from a living donor in the Chair and Department 
of General and Transplant Surgery. The coordinator 
for the living donor plays an important role in the 
“local” healthcare system functioning in the Depart-
ment. The coordinator’s task is to integrate the care 
for the donor, to organise follow-up visits of patients 
and to keep the Register of the Living Donor. 
The programme of care for a living kidney donor 
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the follow-up visits are held at 1, 6 and 12 months 
after surgery and annually for 10 years. At the centre 
employing the author, the visits are held additionally 
at 3 months, and then annually, without a time limit. 
Follow-up examinations and tests are performed in 
the course of one- or two-day hospitalisation. At the 
hospital, donors undergo physical examinations, ima-
ging examinations and biochemical blood and urine 
tests. In justified cases, the diagnostics is expanded 
(e.g. by pressure Holter). Moreover, the health status 
is also assessed in the psychological aspect. In the 
model developed in the Chair and Department of Ge-
neral and Transplant Surgery of the Medical Universi-
ty of Warsaw, a psychologist plays an integral role in 
the care for the kidney donor and recipient. The care 
is provided in cooperation with a team of psycholo-
gists led by Dr Mateusz Zatorski from the University 
of Social Sciences and Humanities in Warsaw.
 
Since 2008, American transplant centres must pro-
vide medical care for the kidney donor for 2 years, 
and the test results are to be transferred to the UNOS 
register.17 Follow-up visits should take place at 3, 6, 
12 and 24 months after hospital discharge, but it is 
not clearly stated whether the follow-up examinations 
and tests are to be performed at the transplant centre 
or in the family physician’s office. (18) In response to 
a question posed in a survey to persons responsible 
for conducting programmes of care for the living do- 
nor at the majority of transplant centres in the USA, 
31% of the respondents considered that care for the 
donor should last for 5 years or more, 30% conside-
red 2 years to be enough, for 32% it was one year, 
and 8% considered up to 6 months to be a sufficient 
period. (17) In Australia, there is no programme of 
care for the living donor and it only depends on the 
living donor whether and how they will follow up on 
their health status. Medical monitoring is conducted 
by the family physician. (19) 
In the study of Mandelbrot et al., (18) the authors 
state that in a large number of American transplant 
centres the only examinations and tests are blood 
pressure measurement, serum creatinine test, gene-
ral and biochemical urin analysis and a physical exa-
mination of the patient. Health status assessment in 
the psychological aspect is performed in the minority 
of cases. In less than half of the cases, a psychologi-
cal assessment of the health status is performed. As 
shown by a study conducted by Waterman et al., (17) 
in the case of assessment of the health status of a li-
ving donor it is necessary to monitor a larger number 
of parameters than monitored so far. 
It arises from the data presented by UNOS that 30% 
of living donors in the USA are not covered by medi-
cal care and there is no information in registers about 
their actual health status. (20) At certain transplant 
centres, living renal donors are not covered by the 
system of care at all. (17) 
In Poland, the data collected at follow-up visits, con-
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should cover the assessment of health status and 
quality of life and an analysis of the data collected on 
the basis of the same criteria. The conclusions drawn 
should be used to assess the risk associated with the 
kidney harvesting procedure, to assess the health 
status of the living donor and to improve the results 
of kidney transplantation from a living donor. 
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TAB. 1.  CONTRAINDICATIONS TO DONATION
Absolute contraindications 
• mental disease precluding an informed decision
• ineffectively treated psychiatric disease
• addiction (alcohol, cigarettes, illicit drugs)
• renal disease symptoms (elevated creatinine level, decreased GFR, 
proteinuria, unexplained haematuria and pyuria)
• significant anatomical anomalies of kidneys
• recurrent nephrolithiasis or bilateral presence of kidney stones
• systemic vascular diseases
• diabetes mellitus
• poorly controlled arterial hypertension
• past myocardial infarction or coronary heart disease in the course 
of treatment
• moderate to severe lung disease
• presence of cancer (except in situ cancer of the skin, uterine cervix 
and colon)
• diagnosis of malignancy in the past (lungs, breasts, urinary tract, 
melanoma, gastrointestinal tract, haematopoietic system)
• family history of clear cell renal carcinoma
• infections
Relative contraindications 
• age below 18 years and above 60 years
• obesity, particularly when BMI > 30 – 35
• moderately well controlled arterial hypertension
• previous single episode of nephrolithiasis
• minor abnormalities of the urinary tract
• young donor with more than one first-degree relative with diabetes 
mellitus or renal diseases in family history




TAB. 2.  EXAMINATIONS AND TESTS PERFORMED IN A  
 POTENTIAL LIVING KIDNEY DONOR
List of examinations and tests
• blood typing




• urinalysis 2 x 
• urine culture 2 x 
• 24-h proteinuria
• microalbuminuria
• thyroid hormones, in justified cases
• virological panel: HCV, HBV, CMV, EBV, HIV, syphilis test
• HBV vaccination




• exercise test if there are ECG and ECHO abnormalities or when age 
> 50 years
• urography, abdominal ultrasound
• dental consultation, pantomogram
• gynaecological consultation and examination, Papanicolaou test, 
pregnancy test (if justified), mammography
• urological consultation, PSA in men aged > 40 years
• psychological consultation
* According to the guidelines of the Amsterdam forum, ABPM is recommen-
ded, especially in prospective donors aged >50 years. (12)
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